Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30000204
Basic Information
VIS ID
TVIS30000204
Fusion event
HIV-ANKFY1 integration
Validated
No
Detection method
NG-SGS
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2018
PubMed ID
30024859
Virus Sequence
Virus name
HIV
Reference genome
K03455.1
Host Sequence
Chromosome
chr17
Cytoband
p13.2
Reference genome
GRCh37/hg19
Start
4097966/4194671 (Hg38)
End
4097966/4194671 (Hg38)
Orient
-
Location type
Intronic
Target gene
ANKFY1
miRNAs that regulate target gene
hsa-mir-155-5p
;
hsa-mir-130b-3p
;
hsa-mir-128-3p
;
hsa-mir-1-3p
;
hsa-mir-103a-3p
;
hsa-mir-101-3p
;
hsa-mir-93-5p
;
hsa-mir-760
;
hsa-mir-106b-5p
;
hsa-mir-4793-3p
;
hsa-mir-7703
;
hsa-mir-374a-5p
;
hsa-mir-374b-5p
;
hsa-mir-4713-5p
;
hsa-mir-218-5p
;
hsa-mir-20a-5p
;
hsa-mir-6720-5p
;
hsa-mir-6512-3p
;
hsa-mir-6729-5p
;
hsa-mir-4649-5p
;
hsa-mir-1273a
;
hsa-mir-661
;
hsa-mir-4486
;
hsa-mir-2116-3p
;
hsa-mir-532-3p
;
hsa-mir-150-5p
;
hsa-mir-766-3p
;
hsa-mir-939-3p
;
hsa-mir-186-3p
;
hsa-mir-6849-3p
;
hsa-mir-508-5p
;
hsa-mir-576-5p
;
hsa-mir-633
;
hsa-mir-4286
;
hsa-mir-877-3p
;
hsa-mir-6513-5p
;
hsa-mir-1224-3p
;
hsa-mir-887-5p
;
hsa-mir-3913-5p
;
hsa-mir-3122
;
hsa-mir-450a-1-3p
;
hsa-mir-6779-5p
;
hsa-mir-6780a-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-6788-5p
;
hsa-mir-1273h-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-7977
;
hsa-mir-30c-1-3p
;
hsa-mir-654-5p
;
hsa-mir-541-3p
;
hsa-mir-920
;
hsa-mir-6726-5p
;
hsa-mir-5591-5p
;
hsa-mir-6090
;
hsa-mir-4300
;
hsa-mir-6827-5p
;
hsa-mir-4761-5p
;
hsa-mir-7855-5p
;
hsa-mir-4710
;
hsa-mir-4792
;
hsa-mir-9-5p
;
hsa-mir-6832-3p
;
hsa-mir-6814-5p
;
hsa-mir-3691-3p
;
hsa-mir-2114-5p
;
hsa-mir-6865-5p
;
hsa-mir-6815-5p
;
hsa-mir-211-5p
;
hsa-mir-204-5p
;
hsa-mir-3162-5p
;
hsa-mir-3649
;
hsa-mir-7112-3p
;
hsa-mir-107
;
hsa-mir-383-3p
;
hsa-mir-34c-3p
;
hsa-mir-4756-5p
;
hsa-mir-4739
;
hsa-mir-1321
;
hsa-mir-6760-5p
;
hsa-mir-193b-3p
;
hsa-mir-519d-3p
;
hsa-mir-193a-3p
;
hsa-mir-20b-5p
;
hsa-mir-17-5p
;
hsa-mir-1197
;
hsa-mir-1224-5p
;
hsa-mir-1293
;
hsa-mir-323a-5p
;
hsa-mir-4483
;
hsa-mir-4651
;
hsa-mir-4751
;
hsa-mir-5004-5p
;
hsa-mir-608
;
hsa-mir-6801-5p
Nearest miRNA
hsa-mir-1253/Upstream/1446489; hsa-mir-10226/Downstream/775031;
Nearest TSS
ENST00000595228/Upstream/3336;
ENST00000616113/Downstream/13461;
Nearest CpG islands
None/Target,
chr17-CpG: 26/Upstream/50598
,
chr17-CpG: 74/Downstream/68739
Upstream sequence
ATCCCTGTTATTTTATTTAGTCAGATCAAGGAAATACATTAAAACAGTGTTCTCAAAGTGTAGtctaatatggtaaatactgaagttataacccacctaa
Downstream sequence
agaaaagctctctggggtacaatttttaagacggtcaaaggaattcttgagtccaaagagtctgcgagtcgccgCATTAAATAAATGGAAGTTTCAGTTT
Reference
Sharaf, R., et al.HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest,2018,128(9): 4074-4085.
Sample Information
×
Sample name
1A5
Sample type
PBMC
Age
36
Gender
Male
CpG Island Information
×
Download
Curate